METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY
US Application 62/992,715
Filed on 2020-03-20
Filed on 2020-03-20
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
US Application 62/981,856
Filed on 2020-02-26
Filed on 2020-02-26
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
US Application 62/976,655
Filed on 2020-02-14
Filed on 2020-02-14
Immunotherapy With An Immuninotoxin and Immunostimulator
US Application 62/927,753
Filed on 2019-10-30
Filed on 2019-10-30
SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES
US Application 62/988,783
Filed on 2020-03-12
Filed on 2020-03-12
METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY
US Application 62/992,701
Filed on 2020-03-20
Filed on 2020-03-20
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION
US Application 62/975,544
Filed on 2020-02-12
Filed on 2020-02-12
RAB13 AND NET1 ANTISENSE OLIGONUCLEOTIDES TO TREAT METASTATIC CANCER
US Application 62/966,204
Filed on 2020-01-27
Filed on 2020-01-27
INHIBITION OF ACTIVE TUMOR DEFENSE TO IMPROVE IMMUNOTHERAPY EFFICACY AND USES THEREOF
US Application 62/956,955
Filed on 2020-01-03
Filed on 2020-01-03
CODEFACS AND LIRICS PIPELINES FOR BULK EXPRESSION DECONVOLUTION
US Application 62/940,755
Filed on 2019-11-26
Filed on 2019-11-26